Bios Capital Management, LP
BIOS Capital Management, LP is an SEC-registered investment adviser headquartered in Fort Worth, Texas. The firm, founded in 2019, employs around 8 staff, primarily investment professionals. BIOS focuses on investments in the healthcare and biotechnology sector, managing capital for institutional investors and high-net-worth individuals, and is known for building concentrated long-term positions in emerging therapeutics and life science companies.
Investment Strategy
BIOS Capital Management adopts a science-driven, long-term investment approach focused on identifying and partnering with innovative life sciences and biotechnology companies. Their strategy emphasizes concentrated holdings in early-stage therapeutics, leveraging deep sector expertise to originate and manage investments in companies developing novel platforms, drugs, or technologies. The firm maintains a hands-on, fundamental research process and prefers higher-conviction positions in the healthcare sector.
Top Holdings
Equity Positions (5)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A ACTU | ACTUATE THERAPEUTICS INC | 83.89% | $60.9M | 9,965,079 | $7.95 | $6.11 | -$6.1M |
L LTRN | LANTERN PHARMA INC | 4.68% | $3.4M | 1,075,952 | $3.19 | $3.16 | -$875.3K |
R RNTX | REIN THERAPEUTICS INC | 3.26% | $2.4M | 1,690,751 | $2.30 | $1.40 | -$625.6K |
C CGTX | COGNITION THERAPEUTICS INC | 2.56% | $1.9M | 6,000,000 | $0.70 | $0.31 | -$664.8K |
I INAB | IN8BIO INC | 0.83% | $599.1K | 286,664 | $7.72 | $2.09 | -$828.5K |